S. Couban

Recommendations of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia

J. Lipton, D. Roy, P. Laneuville, 2006, Current oncology.

G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept

J. Lipton, S. Couban, U. Deotare, 2015, Bone Marrow Transplantation.

CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

S. Mostafavi, T. Panzarella, M. Aljurf, 2017, Haematologica.

CANADIAN CANCER TRIALS GROUP (CCTG) LY.17: A RANDOMIZED PHASE II STUDY EVALUATING NOVEL SALVAGE THERAPY PRE‐AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR‐DLBCL) ‐ OUTCOME OF IBRUTINIB + R‐GDP

A. Prica, J. Kuruvilla, L. Shepherd, 2017 .

Risk Factors of Catheter-Related Thrombosis (CRT) in Cancer Patients: A Patient-Level Data (IPD) Meta-Analysis of Clinical Trials and Prospective Studies

C. Cimminiello, M. Moia, G. Agnelli, 2010 .